Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians
Figure 4
(a–d) Gadoxetate acid-enhanced MRI in the precontrast, arterial, venous, and equilibrium phases of 37-year-old female non-Hepatitis B or C virus carrier showing a large mass in the right lobe of the liver with early arterial enhancement and persistent late-phase enhancement with a small central hypointense scar. (e, f) Gadoxetate acid-enhanced MRI in the hepatobiliary phase 10–20 minutes after injection showing progressively hyperintense enhancement, in a homogeneous pattern apart from the hypointense small central scar. The MRI findings are typical for focal nodular hyperplasia.
